Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Status:
COMPLETED
Trial end date:
2025-08-26
Target enrollment:
Participant gender:
Summary
This is a Phase IV, single arm, multicenter study designed to evaluate the efficacy and safety profile of Sonidegib in chinese participants with locally advanced basal cell carcinoma (laBCC) who are not amenable to radiation therapy, curative surgery or other local therapies.
Phase:
PHASE4
Details
Lead Sponsor:
Jemincare
Collaborators:
Sun Pharmaceutical Industries Limited Zhejiang Hangyu Pharmaceutical Co., Ltd.